Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 352 (LINC00352) is a member of the long non-coding RNA (lncRNA) family and is classified more specifically as a long intergenic non-coding RNA (lincRNA). LincRNAs are autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap with protein-coding genes and generally function in gene regulation, chromatin remodeling, and regulation of transcriptional activity. The specific molecular or physiological roles of LINC00352 are currently unknown, and there is no evidence for its involvement in disease or as a druggable target. LINC00352 is not used clinically for diagnostic, prognostic, or therapeutic purposes.
Not applicable—LINC00352 is not a recognized drug target and has no documented mechanisms of action as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 352 (LINC00352).